NCT01639807

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

A Prospective, Randomized, Controlled Clinical Trial Comparing Topical Medical Therapy With Selective Laser Trabeculoplasty in South Indian Population

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 600 (estimated)
• Sponsor: Aurolab · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare Selective laser trabeculoplasty (SLT) and topical medications for initial treatment of open-angle glaucoma /Ocular Hypertension based on intraocular pressure reduction, treatment side effects, quality of life measures and costs in South Indian Population.

Detailed description

Selective laser trabeculoplasty (SLT), a lasering procedure, is equal to or better than using medication for lowering eye pressure,leading to a better quality of life and being less costly.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Latanoprost	Latanoprost (0.005%) eye drops, once daily in the evening
PROCEDURE	SLT	Selective Laser Trabeculoplasty

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-10-01
• Completion: 2014-12-01
• First posted: 2012-07-13
• Last updated: 2012-07-13

Locations

1 site across 1 country: India